Poxel SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative drugs to treat type 2 diabetes, today announced that Jonae R. Barnes has joined the Company as Senior Vice President, Investor Relations and Public Relations. Ms. Barnes will be based in the Boston area, a leading area in drug development and innovation.
Poxel Appoints Jonae R. Barnes as Senior Vice President Investor Relations and Public Relations, Based in Boston
March 14, 2016
{
unknownx500
More posts by Park Square Executive Search
Recent posts from Park Square Executive Search